These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24011606)

  • 1. Neuropsychological rehabilitation has beneficial effects on perceived cognitive deficits in multiple sclerosis during nine-month follow-up.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2013 Nov; 334(1-2):154-60. PubMed ID: 24011606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
    Mäntynen A; Rosti-Otajärvi E; Koivisto K; Lilja A; Huhtala H; Hämäläinen P
    Mult Scler; 2014 Jan; 20(1):99-107. PubMed ID: 23804555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2013 Nov; 334(1-2):106-11. PubMed ID: 23968849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and impact of the working alliance in the neuropsychological rehabilitation of patients with multiple sclerosis.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2014 Mar; 338(1-2):156-61. PubMed ID: 24433929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
    Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
    J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The possibilities of neuropsychological rehabilitation in multiple sclerosis].
    Rosti-Otajärvi E; Hämäläinen P
    Duodecim; 2010; 126(24):2845-52. PubMed ID: 21268907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial.
    Schwid SR; Goodman AD; Weinstein A; McDermott MP; Johnson KP;
    J Neurol Sci; 2007 Apr; 255(1-2):57-63. PubMed ID: 17331542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of group cognitive rehabilitation therapy in multiple sclerosis.
    Mani A; Chohedri E; Ravanfar P; Mowla A; Nikseresht A
    Acta Neurol Scand; 2018 Jun; 137(6):589-597. PubMed ID: 29411360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive training in MS: effects and relation to brain atrophy.
    Hildebrandt H; Lanz M; Hahn HK; Hoffmann E; Schwarze B; Schwendemann G; Kraus JA
    Restor Neurol Neurosci; 2007; 25(1):33-43. PubMed ID: 17473394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.
    Amato MP; Goretti B; Viterbo RG; Portaccio E; Niccolai C; Hakiki B; Iaffaldano P; Trojano M
    Mult Scler; 2014 Jan; 20(1):91-8. PubMed ID: 23959713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of brain resting state functional connectivity predict the persistence of cognitive rehabilitation effects in patients with multiple sclerosis.
    Parisi L; Rocca MA; Mattioli F; Copetti M; Capra R; Valsasina P; Stampatori C; Filippi M
    Mult Scler; 2014 May; 20(6):686-94. PubMed ID: 24072724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis.
    Mattioli F; Bellomi F; Stampatori C; Capra R; Miniussi C
    Mult Scler; 2016 Feb; 22(2):222-30. PubMed ID: 26014600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term cognitive training improves mental efficiency and mood in patients with multiple sclerosis.
    Brenk A; Laun K; Haase CG
    Eur Neurol; 2008; 60(6):304-9. PubMed ID: 18824859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis.
    Mattioli F; Stampatori C; Zanotti D; Parrinello G; Capra R
    J Neurol Sci; 2010 Jan; 288(1-2):101-5. PubMed ID: 19825502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
    Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
    Patti F; Amato MP; Bastianello S; Caniatti L; Di Monte E; Ferrazza P; Goretti B; Gallo P; Morra VB; Lo Fermo S; Picconi O; Tola MR; Trojano M;
    Mult Scler; 2010 Jan; 16(1):68-77. PubMed ID: 19995846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.
    Goretti B; Portaccio E; Ghezzi A; Lori S; Moiola L; Falautano M; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Cappiello S; Comi G; Trojano M; Amato MP;
    Mult Scler; 2012 Mar; 18(3):329-34. PubMed ID: 21844064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is neuropsychological rehabilitation effective in multiple sclerosis?
    Hämäläinen P; Rosti-Otajärvi E
    Neurodegener Dis Manag; 2014; 4(2):147-54. PubMed ID: 24832032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.